Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veru Inc (NQ: VERU )

0.8111 -0.0178 (-2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 524,100
Open 0.8100
Bid (Size) 0.7900 (1)
Ask (Size) 0.8100 (27)
Prev. Close 0.8289
Today's Range 0.8002 - 0.8450
52wk Range 0.3600 - 1.920
Shares Outstanding 146,383,920
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024
VERU stock results show that Veru beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+12.40%
+12.40%
1 Month
-4.76%
-4.76%
3 Month
-50.24%
-50.24%
6 Month
+84.05%
+84.05%
1 Year
-28.22%
-28.22%

More News

Read More
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Critical Insights From Veru Analyst Ratings: What You Need To Know
Via Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
From FN Media Group LLC
Via GlobeNewswire
Comstock And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
VERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Earnings Scheduled For February 8, 2024
Via Benzinga
6 Analysts Have This to Say About Veru
Via Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN
Via AB Newswire
Exposures Product Safety
The 3 Best Penny Stocks to Buy in February 2024
Via InvestorPlace
8 Consumer Staples Stocks Moving In Tuesday's Intraday Session
Via Benzinga
VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
VERU INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Veru Inc. - VERU
From Kahn Swick & Foti, LLC
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
11 Consumer Staples Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
9 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.